Press Releases - WuXi Biologics
Jan 15, 2025 · Provided as either a standalone service offering or as part of our integrated CMC development platforms, WuXi Biologics provides extensive expertise and industry-leading …
2020 Results Record High Despite a Challenging Year - WuXi …
Mar 23, 2021 · Dr. Chris Chen, CEO of WuXi Biologics, said, “Despite the pandemic, we have been able to overcome the difficulties and achieve outstanding results by drawing on our …
WuXi Biologics and GSK Enter into License Agreement on Multiple …
Jan 5, 2023 · WuXi Biologics will provide an exclusive license to GSK for one preclinical bi-specific T cell engaging (TCE) antibody and the option of three additional bi-/multi-specific …
Company News: 2019-12 - WuXi Biologics
WuXi Vaccines to Build a $240 Million Manufacturing Facility in Ireland . WuXi Biologic’ subsidiary WuXi Vaccines, engaged in human vaccine Contract Development & Manufacturing …
Events – New - WuXi Biologics
Provided as either a standalone service offering or as part of our integrated CMC development platforms, WuXi Biologics provides extensive expertise and industry-leading timelines for cell …
WuXi Biologics
A leading global open-access biologics technology platform offering end-to-end solutions to empower organizations to discover, develop and manufacture biologics from concept to …
Company News: 2020-09 - WuXi Biologics
Provided as either a standalone service offering or as part of our integrated CMC development platforms, WuXi Biologics provides extensive expertise and industry-leading timelines for cell …
Company News: 2022-12 - WuXi Biologics
Provided as either a standalone service offering or as part of our integrated CMC development platforms, WuXi Biologics provides extensive expertise and industry-leading timelines for cell …
Company News: 2023-12 - WuXi Biologics
Our commitment to drive innovation for our clients at the earliest stages of biologics development pertain to both small, venture-backed entities as well as large pharma. Our unique CRDMO …
Company News: 2022-04 - WuXi Biologics
WuXi Biologics Wins CMO Leadership Awards in All Six Core Categories for Fifth Consecutive Year. Read More WuXi Biologics Recognized as 2022 Top-Rated ESG Company by …